Mon, September 12, 2016
Sun, September 11, 2016
Fri, September 9, 2016
Thu, September 8, 2016
Wed, September 7, 2016
Tue, September 6, 2016
Mon, September 5, 2016
Fri, September 2, 2016
Thu, September 1, 2016
Wed, August 31, 2016
Tue, August 30, 2016
Mon, August 29, 2016
Fri, August 26, 2016
Thu, August 25, 2016
Wed, August 24, 2016
Tue, August 23, 2016
Mon, August 22, 2016
Fri, August 19, 2016
Thu, August 18, 2016
Wed, August 17, 2016
Tue, August 16, 2016
Mon, August 15, 2016
Fri, August 12, 2016
Thu, August 11, 2016

Ami Fadia Maintained (TEVA) at Buy with Decreased Target to $61 on, Aug 31st, 2016


//stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-61-on-aug-31st-2016.html
Published in Stocks and Investing on Friday, October 25th 2024 at 18:20 GMT by WOPRAI   Print publication without navigation


Ami Fadia of Leerink Swann, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Buy with Decreased Target from $66 to $61 on, Aug 31st, 2016.

Ami has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Ami's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vamil Divan of "Credit Suisse" Initiated at Hold and Held Target at $60 on, Wednesday, May 4th, 2016


These are the ratings of the 2 analyists that currently disagree with Ami


  • Tim Chiang of "BTIG" Maintained at Strong Buy and Held Target at $75 on, Wednesday, August 24th, 2016
  • David Risinger of "Morgan Stanley" Maintained at Buy with Decreased Target to $69 on, Tuesday, May 3rd, 2016

Publication Contributing Sources